|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
CH0229046H1
(de)
|
1985-03-30 |
1998-07-15 |
Stuart Alan Kauffman |
Method for obtaining dna, rna, peptides, polypeptinique. des or proteins by means of a dna recombinant tech
|
|
US6492107B1
(en)
|
1986-11-20 |
2002-12-10 |
Stuart Kauffman |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
DE3600905A1
(de)
|
1986-01-15 |
1987-07-16 |
Ant Nachrichtentech |
Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
|
|
US5681718A
(en)
|
1986-03-14 |
1997-10-28 |
Celltech Limited |
Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
CA2016841C
(en)
|
1989-05-16 |
1999-09-21 |
William D. Huse |
A method for producing polymers having a preselected activity
|
|
CA2057923A1
(en)
|
1989-05-16 |
1990-11-17 |
William D. Huse |
Co-expression of heteromeric receptors
|
|
CA2016842A1
(en)
|
1989-05-16 |
1990-11-16 |
Richard A. Lerner |
Method for tapping the immunological repertoire
|
|
US5183884A
(en)
|
1989-12-01 |
1993-02-02 |
United States Of America |
Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
DE69127627T2
(de)
|
1990-08-29 |
1998-02-19 |
Genpharm Int |
Produktion und Nützung nicht-menschliche transgentiere zur Produktion heterologe Antikörper
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
ATE164395T1
(de)
|
1990-12-03 |
1998-04-15 |
Genentech Inc |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
WO1992022653A1
(en)
|
1991-06-14 |
1992-12-23 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
ATE408012T1
(de)
|
1991-12-02 |
2008-09-15 |
Medical Res Council |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
ES2202310T3
(es)
|
1991-12-13 |
2004-04-01 |
Xoma Corporation |
Metodos y materiales para la preparacion de dominios variables de anticuerpos modificados y sus usos terapeuticos.
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US6696248B1
(en)
|
1995-08-18 |
2004-02-24 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
|
DK1143006T3
(da)
|
1995-08-18 |
2008-07-14 |
Morphosys Ip Gmbh |
Vektorer/DNA-sekvenser fra humane kombinatoriske antistofbiblioteker
|
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
|
BR9708343A
(pt)
*
|
1996-03-27 |
1999-08-03 |
Genentech Inc |
Anticorpo composição linhagem de células método para determinar a presença de proteína de erbB3 e kit
|
|
US5968511A
(en)
|
1996-03-27 |
1999-10-19 |
Genentech, Inc. |
ErbB3 antibodies
|
|
US5804968A
(en)
|
1997-01-29 |
1998-09-08 |
Picker International, Inc. |
Gradient coils with reduced eddy currents
|
|
US20030105057A1
(en)
|
1997-03-19 |
2003-06-05 |
Yale University |
Methods and compositions for stimulating apoptosis and cell death or for inhibiting cell growth and cell attachment
|
|
WO1998056808A1
(en)
|
1997-06-13 |
1998-12-17 |
Genentech, Inc. |
Protein recovery by chromatography followed by filtration upon a charged layer
|
|
US6417168B1
(en)
|
1998-03-04 |
2002-07-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods of treating tumors
|
|
ZA200007412B
(en)
|
1998-05-15 |
2002-03-12 |
Imclone Systems Inc |
Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases.
|
|
AUPQ105799A0
(en)
|
1999-06-18 |
1999-07-08 |
Victor Chang Cardiac Research Institute, The |
Cell growth inhibition
|
|
NZ516830A
(en)
|
1999-06-25 |
2004-07-30 |
Genentech Inc |
Humanized anti-ErbB2 antibodies conjugated with a cytotoxic or chemotherapeutic agent for treating cancer
|
|
ATE482275T1
(de)
|
1999-07-02 |
2010-10-15 |
Morphosys Ag |
Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden
|
|
US7390632B2
(en)
|
1999-09-30 |
2008-06-24 |
Tumor Biology Investment Group, Inc. |
Soluble ErbB3 receptor isoforms
|
|
US7097840B2
(en)
|
2000-03-16 |
2006-08-29 |
Genentech, Inc. |
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
|
|
WO2001089566A1
(en)
|
2000-05-19 |
2001-11-29 |
Genentech, Inc. |
Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
|
|
US7658921B2
(en)
|
2000-12-12 |
2010-02-09 |
Medimmune, Llc |
Molecules with extended half-lives, compositions and uses thereof
|
|
WO2002060919A2
(en)
|
2000-12-12 |
2002-08-08 |
Medimmune, Inc. |
Molecules with extended half-lives, compositions and uses thereof
|
|
EP1228766A1
(en)
|
2001-01-31 |
2002-08-07 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
PYK2 phosphorylation by HER3 induces tumor invasion
|
|
US20040138160A1
(en)
|
2001-04-27 |
2004-07-15 |
Kenichiro Naito |
Preventive/therapeutic method for cancer
|
|
WO2002087618A1
(en)
|
2001-04-27 |
2002-11-07 |
Takeda Chemical Industries, Ltd. |
Preventive/therapeutic method for cancer
|
|
US7744882B2
(en)
|
2001-05-31 |
2010-06-29 |
Tumor Biology Investment Group, Inc. |
Soluble ErbB3 methods of detection and antibodies
|
|
US7638302B2
(en)
|
2001-05-31 |
2009-12-29 |
Tumor Biology Investment Group, Inc. |
Soluble ErbB3 receptor isoforms
|
|
EP2277542B1
(en)
|
2001-06-01 |
2014-04-16 |
Cornell Research Foundation Inc. |
Modified antibodies to prostrate-specific membrane antigen and uses thereof
|
|
JP4298498B2
(ja)
|
2001-06-13 |
2009-07-22 |
ゲンマブ エー/エス |
上皮成長因子受容体(egfr)に対するヒトモノクローナル抗体
|
|
ATE440869T1
(de)
|
2001-06-20 |
2009-09-15 |
Fibron Ltd |
Fgfr3 blockierende antikírper, verfahren zum screening darauf und verwendungen davon
|
|
US7125680B2
(en)
|
2001-07-27 |
2006-10-24 |
The Regents Of The University Of California |
Methods and materials for characterizing and modulating interaction between heregulin and HER3
|
|
AU2002326531A1
(en)
|
2001-08-03 |
2003-02-17 |
The Trustees Of The University Of Pennsylvania |
Monoclonal antibodies to activated erbb family members and methods of use thereof
|
|
EP1283053A1
(en)
*
|
2001-08-09 |
2003-02-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inhibitors of HER3 activity
|
|
DK1472275T3
(da)
|
2002-02-05 |
2009-04-14 |
Genentech Inc |
Proteinoprensning
|
|
US7591994B2
(en)
|
2002-12-13 |
2009-09-22 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
|
PL230179B1
(pl)
|
2002-03-13 |
2018-09-28 |
Array Biopharma Inc |
N3 Alkilowane pochodne benzoimidazolu, kompozycja je zawierająca oraz ich zastosowanie do wytwarzania leku do leczenia zaburzeń hiperproliferacyjnych
|
|
AU2003218600C1
(en)
|
2002-03-26 |
2009-12-17 |
Zensun (Shanghai) Science & Technology Co., Ltd. |
ERBB3 based methods and compositions for treating neoplasms
|
|
US7332580B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The University Of California |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
US7332585B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
DK1501369T3
(en)
|
2002-04-26 |
2015-09-28 |
Genentech Inc |
Non-affinity purification of proteins
|
|
US20040229380A1
(en)
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB heterodimers as biomarkers
|
|
US20040229299A1
(en)
|
2002-05-21 |
2004-11-18 |
Badal M. Youssouf |
Intracellular complexes as biomarkers
|
|
US20040229293A1
(en)
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
Surface receptor complexes as biomarkers
|
|
US7402397B2
(en)
|
2002-05-21 |
2008-07-22 |
Monogram Biosciences, Inc. |
Detecting and profiling molecular complexes
|
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
AT413486B
(de)
|
2002-07-03 |
2006-03-15 |
Igeneon Krebs Immuntherapie |
Verwendung eines antikörpers gerichtet gegen lewis-antigene
|
|
EP2263691B1
(en)
|
2002-07-15 |
2012-08-29 |
F.Hoffmann-La Roche Ag |
Treatment of cancer with the recombinant humanized monoclonal anti-erbb2 antibody 2C4 (rhuMAb 2C4)
|
|
GB0216648D0
(en)
|
2002-07-18 |
2002-08-28 |
Lonza Biologics Plc |
Method of expressing recombinant protein in CHO cells
|
|
AU2003258061A1
(en)
|
2002-08-02 |
2004-02-23 |
Salmedix, Inc. |
Therapeutic inhibitionof protein kinases in cancer cells
|
|
JPWO2004026341A1
(ja)
|
2002-09-19 |
2006-01-12 |
株式会社オリエントキャンサーセラピー |
ガンの免疫治療剤
|
|
SI1578446T1
(sl)
|
2002-11-07 |
2015-07-31 |
Immunogen, Inc. |
Protitelesa proti-cd33 in metoda za zdravljenje akutne mieloidne levkemije z uporabo istega
|
|
WO2004065417A2
(en)
|
2003-01-23 |
2004-08-05 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
|
AU2004215133B2
(en)
|
2003-02-27 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection
|
|
KR20110094361A
(ko)
|
2003-04-11 |
2011-08-23 |
메디뮨 엘엘씨 |
재조합 il9 항체 및 그의 용도
|
|
TW568408U
(en)
|
2003-05-14 |
2003-12-21 |
High Tech Comp Corp |
Slide structure
|
|
JP2007500248A
(ja)
|
2003-06-09 |
2007-01-11 |
ワクサル,サムエル |
細胞外アンタゴニストおよび細胞内アンタゴニストによる受容体チロシンキナーゼの抑制方法
|
|
EP1493445A1
(en)
|
2003-07-04 |
2005-01-05 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inhibition of stress-induced ligand-dependent EGFR activation
|
|
HUE029951T2
(en)
|
2003-07-28 |
2017-04-28 |
Genentech Inc |
Reduction of Protein A Dissolution in Protein A Affinity Chromatography
|
|
US20060204966A1
(en)
|
2003-08-01 |
2006-09-14 |
Spector Neil L |
Treatment of cancers expressing p95 erbb2
|
|
JP2007510708A
(ja)
|
2003-11-06 |
2007-04-26 |
ファイザー・プロダクツ・インク |
癌の治療における選択的erbB2阻害剤/抗erbB抗体の組合せ
|
|
WO2005075514A2
(en)
|
2004-03-10 |
2005-08-18 |
Lonza Ltd. |
Method for producing antibodies
|
|
JP4969440B2
(ja)
|
2004-04-08 |
2012-07-04 |
デビッド, ビー. エイガス, |
疼痛治療のためのErbBアンタゴニスト
|
|
BRPI0510716A
(pt)
|
2004-05-05 |
2007-11-20 |
Merrimack Pharmaceuticals Inc |
uso de um agente de ligação bi-especìfico, agente de ligação bi-especìfico, composição de um agente de ligação bi-especìfico, e, kit
|
|
CA2581208A1
(en)
|
2004-08-30 |
2006-03-09 |
Lonza Biologics Plc. |
Affinity- plus ion exchange- chromatography for purifying antibodies
|
|
AU2005294347A1
(en)
|
2004-10-05 |
2006-04-20 |
Oregon Health And Science University |
Compositions and methods for treating disease
|
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
US20070009972A1
(en)
|
2005-02-16 |
2007-01-11 |
Ginger Chao |
Epidermal growth factor receptor polypeptides and antibodies
|
|
EP1850874B1
(en)
|
2005-02-23 |
2013-10-16 |
Genentech, Inc. |
Extending time to disease progression or survival in ovarian cancer patients using pertuzumab
|
|
KR20080004480A
(ko)
|
2005-03-07 |
2008-01-09 |
타게티드 몰레큘라 다이아그노스틱스, 엘엘씨 |
티로신 키나제 억제제 조성물, 그의 제조 방법 및 이를이용한 질병 치료 방법
|
|
WO2006133460A2
(en)
|
2005-06-09 |
2006-12-14 |
Yale University |
Methods for diagnosing and treating breast cancer based on a her/er ratio
|
|
PE20070207A1
(es)
|
2005-07-22 |
2007-03-09 |
Genentech Inc |
Tratamiento combinado de los tumores que expresan el her
|
|
CN101309933A
(zh)
*
|
2005-09-07 |
2008-11-19 |
米迪缪尼有限公司 |
毒素偶联的Eph受体抗体
|
|
JP2009506790A
(ja)
|
2005-09-07 |
2009-02-19 |
メディミューン,エルエルシー |
毒素とコンジュゲートしたeph受容体抗体
|
|
TWI405756B
(zh)
|
2005-12-21 |
2013-08-21 |
Array Biopharma Inc |
新穎硫酸氫鹽
|
|
JP5474354B2
(ja)
|
2005-12-30 |
2014-04-16 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
AR056857A1
(es)
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
|
US7897723B2
(en)
|
2006-04-07 |
2011-03-01 |
Københavns Universitet |
ErbB receptor-derived peptide fragments
|
|
CA2639070A1
(en)
|
2006-04-13 |
2007-11-01 |
Oncomethylime Sciences S.A. |
Novel tumour suppressor
|
|
EP2091975A4
(en)
|
2006-11-21 |
2013-05-22 |
Univ California |
ANTIBODIES TO THE EGFR FAMILY, BICE-SPECIFIC ANTIBODIES TO THE EGFR FAMILY AND METHOD FOR THEIR USE
|
|
WO2008064884A1
(en)
|
2006-11-28 |
2008-06-05 |
U3 Pharma Gmbh |
Activated her3 as a marker for predicting therapeutic efficacy
|
|
US8652466B2
(en)
|
2006-12-08 |
2014-02-18 |
Macrogenics, Inc. |
Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting
|
|
US8362217B2
(en)
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
US7825127B2
(en)
|
2006-12-28 |
2010-11-02 |
Takeda Pharmaceutical Company, Limited |
Method for treating cancer
|
|
WO2008081331A2
(en)
|
2006-12-29 |
2008-07-10 |
Sinomab Bioscience Limited |
Enhancing the level of antibody expression by framework re-engineering
|
|
US7691980B2
(en)
|
2007-01-09 |
2010-04-06 |
Bio-Rad Laboratories, Inc. |
Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
|
|
ES2431940T3
(es)
|
2007-02-16 |
2013-11-28 |
Merrimack Pharmaceuticals, Inc. |
Anticuerpos contra la ERBB3 y usos de los mismos
|
|
JP2010520225A
(ja)
|
2007-03-02 |
2010-06-10 |
ジェネンテック, インコーポレイテッド |
低her3発現に基づくher二量化インヒビターに対する応答を予測する方法
|
|
ES2407957T3
(es)
|
2007-03-09 |
2013-06-17 |
Geron Corporation |
Tratamiento de carcinomas con una combinación de inhibidores de la vía EGF y de la telomerasa
|
|
ES2593484T3
(es)
|
2007-03-29 |
2016-12-09 |
Genmab A/S |
Anticuerpos biespecíficos y métodos de producción de los mismos
|
|
CA2683559C
(en)
|
2007-04-13 |
2019-09-24 |
Dana Farber Cancer Institute, Inc. |
Methods for treating cancer resistant to erbb therapeutics
|
|
US20090258005A1
(en)
|
2007-05-29 |
2009-10-15 |
Trubion Pharmaceuticals Inc. |
Therapeutic compositions and methods
|
|
US20110091473A1
(en)
|
2007-10-22 |
2011-04-21 |
Genmab A/S |
Novel antibody therapies
|
|
KR20100097716A
(ko)
*
|
2007-11-27 |
2010-09-03 |
아블린쓰 엔.브이. |
이종이량체 사이토킨 및/또는 이의 수용체에 대한 아미노산 서열과 이를 포함하는 폴리펩티드
|
|
EP2275431A3
(en)
|
2008-01-18 |
2011-05-25 |
Bio-Rad Laboratories, Inc. |
Enhanced fractionation of phosphorylated and nonphosphorylated biomolecules by apatite chromotography
|
|
JP5470817B2
(ja)
|
2008-03-10 |
2014-04-16 |
日産自動車株式会社 |
電池用電極およびこれを用いた電池、並びにその製造方法
|
|
WO2009125039A1
(es)
|
2008-04-09 |
2009-10-15 |
Universidad De Barcelona |
Anticuerpos para el tratamiento del cáncer
|
|
CN102057054B
(zh)
|
2008-04-11 |
2015-06-10 |
梅里麦克制药股份有限公司 |
人血清白蛋白接头以及其结合物
|
|
WO2009157919A1
(en)
|
2008-06-23 |
2009-12-30 |
Tumor Biology Investment Group, Inc. |
SOLUBLE ErbB3 DETECTION, REGULATION AND TREATMENT OF CANCER
|
|
EP2138511A1
(en)
|
2008-06-27 |
2009-12-30 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
HER3 as a determinant for the prognosis of melanoma
|
|
EP2159836B1
(en)
|
2008-08-25 |
2017-05-31 |
Soitec |
Stiffening layers for the relaxation of strained layers
|
|
WO2010054051A1
(en)
|
2008-11-07 |
2010-05-14 |
Santaris Pharma A/S |
Erbb-3 (her3)-selective combination therapy
|
|
CN102256993A
(zh)
|
2008-12-16 |
2011-11-23 |
米利波尔公司 |
蛋白的纯化
|
|
CN102326081B
(zh)
|
2009-02-24 |
2014-11-19 |
霍夫曼-拉罗奇有限公司 |
s-ErbB-3作为癌症标志物的应用
|
|
KR20150036824A
(ko)
|
2009-03-20 |
2015-04-07 |
제넨테크, 인크. |
이중특이적 항-her 항체
|
|
WO2010129304A2
(en)
|
2009-04-27 |
2010-11-11 |
Oncomed Pharmaceuticals, Inc. |
Method for making heteromultimeric molecules
|
|
CA2759792A1
(en)
|
2009-04-29 |
2010-11-04 |
Trellis Bioscience, Inc. |
Improved antibodies immunoreactive with heregulin-coupled her3
|
|
US20120107270A1
(en)
|
2009-06-30 |
2012-05-03 |
Manuela Kaspar |
Immunocytokines In Combination With Anti-ErbB Antibodies For The Treatment Of Cancer
|
|
WO2011019620A1
(en)
|
2009-08-10 |
2011-02-17 |
Genentech, Inc. |
Antibodies with enhanced adcc function
|
|
US20120195831A1
(en)
*
|
2009-10-09 |
2012-08-02 |
Ningyan Zhang |
Generation, characterization and uses thereof of anti-her3 antibodies
|
|
WO2011047180A1
(en)
|
2009-10-14 |
2011-04-21 |
Merrimack Pharmaceuticals, Inc. |
Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof
|
|
DK3351558T3
(da)
|
2009-11-13 |
2020-06-02 |
Daiichi Sankyo Europe Gmbh |
Materiale og fremgangsmåder til behandling eller forebyggelse af her-3-relaterede sygdomme
|
|
DK2516469T3
(en)
*
|
2009-12-22 |
2016-05-02 |
Roche Glycart Ag |
ANTI-HER3 antibodies and uses thereof
|
|
EA201201186A1
(ru)
|
2010-03-11 |
2013-11-29 |
Мерримак Фармасьютикалс, Инк. |
ИСПОЛЬЗОВАНИЕ ErbB3 ИНГИБИТОРОВ В ЛЕЧЕНИИ ТРИЖДЫ НЕГАТИВНОГО И БАЗАЛЬНО-ПОДОБНОГО ВИДОВ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ
|
|
JP5906233B2
(ja)
|
2010-04-09 |
2016-04-20 |
アベオ ファーマシューティカルズ, インコーポレイテッド |
抗ErbB3抗体
|
|
WO2011153383A1
(en)
|
2010-06-04 |
2011-12-08 |
Bipar Science, Inc. |
Methods of treating platinum-resistant recurrent ovarian cancer with 4-iodo-3-nitrobenzamide in combination with an anti-metabolite and a platinum compound
|
|
WO2012019024A2
(en)
|
2010-08-04 |
2012-02-09 |
Immunogen, Inc. |
Her3-binding molecules and immunoconjugates thereof
|
|
JP2013540694A
(ja)
|
2010-08-06 |
2013-11-07 |
ウー3・フアルマ・ゲー・エム・ベー・ハー |
Her3結合剤の前立腺治療における使用
|
|
PT2606070T
(pt)
*
|
2010-08-20 |
2017-03-31 |
Novartis Ag |
Anticorpos para o recetor 3 do fator de crescimento epidérmico (her3)
|
|
TW201302793A
(zh)
|
2010-09-03 |
2013-01-16 |
Glaxo Group Ltd |
新穎之抗原結合蛋白
|
|
AU2011317743B2
(en)
|
2010-10-18 |
2015-05-21 |
Mediapharma S.R.L. |
ErbB3 binding antibody
|
|
PL2635604T3
(pl)
|
2010-11-01 |
2017-09-29 |
Symphogen A/S |
Kompozycja przeciwciała PAN-HER
|
|
EA201301025A1
(ru)
|
2011-03-15 |
2014-01-30 |
Мерримак Фармасьютикалс, Инк. |
Преодоление устойчивости к ингибиторам пути erbb
|
|
WO2012176779A1
(ja)
|
2011-06-20 |
2012-12-27 |
協和発酵キリン株式会社 |
抗erbB3抗体
|
|
EP2760893B1
(en)
|
2011-09-30 |
2018-09-12 |
Regeneron Pharmaceuticals, Inc. |
Anti-erbb3 antibodies and uses thereof
|
|
WO2013071058A1
(en)
|
2011-11-09 |
2013-05-16 |
The Uab Research Foundation |
Her3 antibodies and uses thereof
|
|
AU2012340766B2
(en)
|
2011-11-23 |
2018-05-10 |
Medimmune, Llc |
Binding molecules specific for HER3 and uses thereof
|
|
EP3590538A1
(en)
|
2011-12-05 |
2020-01-08 |
Novartis AG |
Antibodies for epidermal growth factor receptor 3 (her3)
|
|
EP3620447B1
(en)
|
2012-03-29 |
2021-02-17 |
Translate Bio, Inc. |
Ionizable cationic lipids
|
|
JP6136279B2
(ja)
|
2013-01-15 |
2017-05-31 |
株式会社ジェイテクト |
転がり軸受装置
|
|
TWI503850B
(zh)
|
2013-03-22 |
2015-10-11 |
Polytronics Technology Corp |
過電流保護元件
|
|
US11305012B2
(en)
*
|
2013-09-24 |
2022-04-19 |
Medimmune, Llc |
Binding molecules specific for HER3 and uses thereof
|
|
TWI510996B
(zh)
|
2013-10-03 |
2015-12-01 |
Acer Inc |
控制觸控面板的方法以及使用該方法的可攜式電腦
|
|
US10745490B2
(en)
*
|
2014-04-11 |
2020-08-18 |
Celldex Therapeutics, Inc. |
Anti-ErbB antibodies and methods of use thereof
|
|
US20170190788A1
(en)
|
2014-09-11 |
2017-07-06 |
Bulldog Pharmaceuticals, Inc. |
Uses of anti-her3 antibodies for treating cancer
|
|
US9816280B1
(en)
|
2016-11-02 |
2017-11-14 |
Matthew Reitnauer |
Portable floor
|